Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinoff
MedTech
Grail to become an Illumina spinout, once again, and go public
The company’s board of directors has approved the plan for Grail to join the Nasdaq, under the ticker “GRAL,” before the end of this month.
Conor Hale
Jun 3, 2024 5:45pm
BridgeBio taps VCs for $200M to fund cancer-focused spinout
May 2, 2024 7:00am
Solventum gets the ball rolling after 3M spinout
Apr 2, 2024 12:35pm
ZimVie begets Highridge Medical with spine business spinout
Apr 1, 2024 11:41am
Masimo to split from consumer tech, baby monitor, smartwatches
Mar 25, 2024 2:02pm
Medtronic's Frank Chan talks about reborn patient monitoring arm
Mar 12, 2024 3:10pm
